Reuters Stock Buzz Powered by SocialPicks Logo_divider Logo_thomsonreuters Bg_dots_d1
   Sign Up   |   Log In   |   What is Reuters Stock Buzz?   |   FAQ powered by Logo_powered_by_socialpicks

 Amylin Pharmaceuticals Inc  (AMLN)     Rate AMLN  -  Discuss AMLN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
50.0%
Top:
100.0%
Rate AMLN:



AMLN: Bull or Bear?

-33.86%
 risk: high
Bullish on AMLN ...  08/13/08
AMLN is getting streangth from from its last successful second quarter where sale of product increased 20% wrote in a research note Analyst Shah from Stock Mania.

Sad
+2.47%
 risk: low
Uptrend for Amylin?  08/06/08
Broke through resistance, following a gap up, on the way to testing the 34 resistance again? Recent buyers all within the 28-29 zone so there is a good support zone there. Technical idea, follow the trend line.

Foto
-4.25%
 risk: low
Amylin Pharmaceuticals Inc.  06/22/08
Amylin and Mallinckrodt amended their manufacturing agreement dated October 1, 2003, pursuant to which Mallinckrodt manufactures and supplies to Amylin bulk exenatide, the active ingredient in BYETTA injection. Under the terms of the Amendment, the termination date of agreement has been extended for a period of four years to September 30, 2012. ...




People Bullish on AMLN

A. Reza Saadat
Pro Track Account
N/A
2 days ago

Tradermark
Trader Mark
Analyst
53%
3 days ago

shahanaym
Analyst
N/A
16 days ago

Sad
Kenny Shen
Analyst
67%
23 days ago

Foto
Marian Filo
Principal
36%
2 mos ago


People Bearish on AMLN

Zacks.com
Tracked Blogger
47%
2 mos ago

Mvc-852f
caho
Analyst
 2 %
about 1 year ago

kkp
Analyst
N/A
about 1 year ago

 


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Amylin Pharmaceuticals Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters